Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Sparsha Pharma Usa Inc
FDA Inspection
•Sparsha Pharma Usa Inc•April 28, 2017

Sparsha Pharma Usa Inc – FDA Inspection, Apr 28, 2017

Record Details

This FDA Inspection record concerns Sparsha Pharma Usa Inc, with an inspection on April 28, 2017, issued by the Center for Devices and Radiological Health, covering devices.

Company
Sparsha Pharma Usa Inc
Inspection Date
April 28, 2017
Product Type
Devices
Office
Center for Devices and Radiological Health
People
  • Cassandra L. Abellard (Company Rep)
  • Marcus F. Yambot (FDA Associated Person)
  • Sonya L. Karsik (FDA Associated Person)
  • Theresa Kirkham
  • Walden H. Lee (FDA Associated Person)
View Company Profile

ID · f436042b-bd2b-4515-bdfb-88644f1f9dee

Inspection Facts

Official Action Indicated (OAI)

Significant objectionable conditions were found and regulatory or administrative action is recommended.

Inspection number
1010514
FDA center
Medical Devices & Rad Health
Project area
Compliance: Devices
Outcome
Form 483 issued

FDA Citations

21
  1. 21 CFR 211.100(a)Changes to Procedures Not Reviewed, Approved
  2. 21 CFR 211.110(b)In-process materials specifications
  3. 21 CFR 211.160(a)Lab controls established, including changes
  4. 21 CFR 211.165(e)Test methods
  5. 21 CFR 211.192Written record of investigation incomplete
  6. 21 CFR 211.194(a)Complete test data included in records
  7. 21 CFR 211.22(a)Authority lacking to review records, investigate errors
  8. 21 CFR 211.63Equipment Design, Size and Location
  9. 21 CFR 211.68(b)Computer control of master formula records
  10. 21 CFR 211.68(b)input/output verification

Showing 10 of 21 citations.

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Sparsha Pharma Usa Inc

2
DateClassificationOfficeProject area
September 3, 2026Not classifiedLos Angeles District OfficeGeneric Drug Evaluation
September 4, 2025VAILos Angeles District OfficeDrug Quality Assurance
Other documents for Sparsha Pharma Usa Inc
  • FDA Inspection 1334198 - 2026-09-03
  • FDA Inspection 1280450 - 2025-09-04

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Sparsha Pharma Usa Inc
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.